Hiroyuki Inuzuka

机构：Beth Israel Deaconess Medical Center, Harvard University, Hadassah Medical Center · ORCID：0000-0002-4892-0047

发表论文 218 篇 · 总被引 10537 次 · h-index 55

代表论文

• Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications (2026 · Signal Transduction and Targeted Therapy · 被引 46)
• USP28-Based Deubiquitinase-Targeting Chimeras for Cancer Treatment (2025 · Journal of the American Chemical Society · 被引 23)
• Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives (2025 · Molecules · 被引 21)
• Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization (2025 · Journal of the American Chemical Society · 被引 14)
• Dual membrane receptor degradation via folate receptor targeting chimera (2025 · Nature Communications · 被引 10)
• Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy (2025 · Journal of the American Chemical Society · 被引 8)